Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor

Using an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.

by Kate Yandell

The first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.

by Liza Bernstein

The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.

by Anna Azvolinsky

A study illuminates the alcohol consumption habits of cancer survivors.

by Jen Tota McGivney

A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.

by Adam P. Stern

The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.

by Emma Yasinski

A study shows that some cancer patients wish they had known more about possible adverse effects of treatment.

by Jon Kelvey

Amanda Rose Ferraro's leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”

by Amanda Rose Ferraro

Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.

by Anna Azvolinsky